Exemplis Discimus 2000, 144(2):51-54

Maecenas nunc massa, convallis ac, accumsan ornare, faucibus in, turpis.

Ravra Kienaan, Noble Barizaan
1st Clinic of Pharmacology, University Hospital of Bothawui, Alderaan Republic

Sed dolor est, porttitor ac, tempor ac, sagittis et, arcu. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Phasellus in massa cursus mauris porttitor condimentum. Proin turpis augue, laoreet sed, venenatis eu, dignissim eu, mauris. Cras metus ipsum, aliquam sit amet, ultricies non, ultrices eget, eros. Fusce risus urna, dignissim a, convallis vel, volutpat sit amet, nunc. Aenean lectus metus, tincidunt ullamcorper, auctor vitae, dapibus nec, est.. Nullam orci leo, porttitor non, rhoncus nec, congue porttitor, magna.

Kµúčové slová: Maecenas odio, Phasellus vestibulum, Ut ante, Donec pede, Nulla facilisi

Uverejnené: December 1, 2000 

Zobrazi» celý článok

Referencie

  1. Brouillard, M., Katz, K. O., Henning, N. P., Reimann, D. S., Myers, B. (1998): Chronic interstitial nephritis and mesalazine: 3 new cases? Gastroenterol. Clin. Biol., 22, 724-726. Prejs» na PubMed...
  2. Popoola, J., Muller, A. F., Pollock, L., ODonnell, P., Carmichael, P., Stevens, P. (1998): Late onset interstitial nephritis associated with mesalazine treatment. BMJ, 317, 795-797. DOI: 10.1136/bmj.317.7161.795 Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  3. Calvino, J., (1998): Mesalazine-associated tubulo-interstitial nephritis in inflammatory bowel disease. Clin. Nephrol., 49, 265-267. Prejs» na PubMed...
  4. Noble, E., Janssen, L., Dierick, P. J. (1997): Comparative cytotoxicity of 5-aminosalicylic acid (mesalazine) and related compounds in different cell lines. Cell. Biol. Toxicol., 13, 445-451. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  5. Hamling, J., Raedler, A., Helmchen, U., Schreiber, S. (1997): 5-Aminosalicylic acid-associated renal tubular acidosis with decreased renal function in Crohns disease. Digestion, 58, 304-307. DOI: 10.1159/000201459 Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  6. World, M. J., Stevens, P. E., Ashton, M. A., Rainford, D. J. (1996): Mesalazine-associated interstitial nephritis. Nephrol. Dial. Transplant., 11, 614-621. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  7. Garcia-Diaz, M., (1995): Acute renal failure associated with 5-aminosalicylic acid in inflammatory bowel disease. Gastroenterol. Hepatol., 18, 18-21. Prejs» na PubMed...
  8. Smilde, T. J., van Liebergen, F. J., Koolen, M. I., Gerlag, P. G., Assman, K. J., Berolen, J. H. (1994): Tubulointerstitial nephritis caused by mesalazine (5-ASA) agents. Ned. Tijdschr. Geneeskd., 138, 2557-2561. Prejs» na PubMed...
  9. Thuluvath, P. J., Ninkovic, M., Calam, J., Anderson, M. (1994): Mesalazine induced intersticial nephritis. Gut, 35, 1493-1496. DOI: 10.1136/gut.35.10.1493 Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  10. Novis, B. H., Korzets, Z., Chen, P., Bernheim, J. (1988): Nephrotic syndrome after treatment with 5-aminosalicylic acid. BMJ, 296, 1442. DOI: 10.1136/bmj.296.6634.1442 Prejs» k pôvodnému zdroju...
  11. Barbour, V. M., Williams, P. F. (1990): Nephrotic syndrome associated with sulphasalazine. BMJ, 301, 818. DOI: 10.1136/bmj.301.6755.818-b Prejs» k pôvodnému zdroju...
  12. Calder, I. C., Funder, C. C., Green, C. R., Ham, K. N., Tange, J. D. (1972): Nephrotoxic lesions from 5-aminosalicylic acid. Br. Med. J., 1, 152-154. Prejs» k pôvodnému zdroju... Prejs» na PubMed...

Spä» na obsah